Are β2-agonists safe in patients with acute exacerbations of COPD?

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 4, 2007, Pages 322-323

  Joos, Guy F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; PLACEBO; SALBUTAMOL; SALMETEROL; TERBUTALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ACUTE HEART INFARCTION; BREATHING MECHANICS; CARDIOVASCULAR EFFECT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; DRUG SAFETY; EDITORIAL; FORCED EXPIRATORY VOLUME; HEADACHE; HEART PALPITATION; HEART RATE; HOSPITALIZATION; HUMAN; LUNG VENTILATION PERFUSION RATIO; MORBIDITY; MORTALITY; NAUSEA; OXYGEN BREATHING; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SINUS TACHYCARDIA; SPIROMETRY; TREMOR; DRUG EFFECT; LUNG GAS EXCHANGE; NEBULIZER; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; CHOLINERGIC ANTAGONISTS; HUMANS; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY GAS EXCHANGE;

EID: 34547935047     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200704-643ED     Document Type: Editorial

References (16)

1. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154:959-967.
2. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003;124:459-467.
3. Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
4. Stoller JK. Clinical practice: acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;346:988-994.
5. National Institute for Health and Clinical Excellence. Management of exacerbations of COPD. Thorax 2004;59(Suppl 1):i131-i156.
6. O'Donnell DE, Parker CM. COPD exacerbations. 3: Pathophysiology. Thorax 2006;61:354-361.
7. Barbera JA, Roca J, Ferrer A, Felez MA, Diaz O, Roger N, Rodriguez-Roisin R. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997;10:1285-1291.
8. Wagner PD. Ventilation, perfusion matching. In: Laurent GF, Shapiro SD, editors. Encyclopedia of respiratory medicine, vol. 4. Oxford, San Diego: Elsevier; 2006. pp. 470-478.
9. Khoukaz G, Gross NJ. Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease: comparison with albuterol and ipratropium. Am J Respir Crit Care Med 1999;160:1028-1030.
10. Hall CS. Beta-agonists. In: Laurent GF, Shapiro SD, editors. Encyclopedia of respiratory medicine, vol. 1. Oxford, San Diego: Elsevier; 2006. pp. 288-292.
11. 2- agonists in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2007;176:350-355.
12. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-1613.
13. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004;125:2309-2321.
14. Suissa S, Assimes T, Ernst P. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Thorax 2003;58:43-46.
15. McCrory DC, Brown LE. Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease (review). The Cochrane Library 2003(issue 1):1-24.
16. Global Initiative for Chronic Obstructive Pulmonary Disease. Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2006. [Accessed 2007 Apr 26]. Available from: www.goldcopd.com